IKN

Take physic, pomp

Canada’s National Bank downgrades Candente Copper (DNT.to) and drops its price target on the stock

Here are the highlight bullets from the National Bank Financial (NBF) report, out this morning.

1) Feasibility study delayed to incorporate new design elements and follow-up drilling at Canariaco Norte. Timing of feasibility study delayed, mostly to incorporate a larger SAG mill design (40ft) and associated production (100k to 110k tpd vs. 95k tpd old) and cost implications. Originally scheduled for H1 2012, the feasibility study will now be delayed by several months/quarters, in turn heightening what is already notable timing risk for project development.

2) Industry bottlenecks remain, with Peru in the thick of things. Owing to the large number of projects planned for development in the 2013-2016 period execution and timing risk are perhaps more concerning to us than capex creep. Peru appears especially vulnerable, with $30 bln in project development planned in the next several years. This will present unique challenges to Candente. In our opinion, an even larger project will only serve to exacerbate timing and cost pressures in the face of still competition for engineering and construction services.

3) Model changes drive NAV decrease. To account for feasibility study delays and our expectation of timing and project execution risk in Peru, we have moved our project start date assumption to 2017 from 2016 previously. The net effect sees our f.d., f.f. NAV8% est. drop to $2.66/sh from $2.95/sh.

4) Lowering target to $1.65 from $2.10 and moving to Sector Perform from Outperform. Target based on 75% (60% old) wt. to 0.6x our NAV8% est. and 25% (40% old) wt. to $0.02/lb ($0.025/lb old) of Cu resource. We are lowering wt. to M&A and EV/lb multiples to account for reduced M&A activity and that acquirers are exposed to heightened capex and timing risk.

IKN back and though I generally agree with the NBF call here (see yesterday’s IKN post), if I were feeling cynical* I’d say that this NBF report is more about “well guys, we got too optimistic about this thing a while back and this gives us a decent excuse to pull back towards reality” than it is a quantitative assessment of DNT.to…but that’s just me. Worth noting that Cormark reported briefly on DNT.to this morning and kept its $2.25 price target in place.
Disclosure: No position in DNT.to

*permanently

Leave a Reply